Aims: To conduct a population-based study comparing age-and sex-specific risk estimates of heart failure (HF) between people with type 2 diabetes and people without diabetes, and to investigate the risks of HF in association with type 2 diabetes in people with various coronary heart diseases (CHDs).
Maintenance Organization (HMO), 3, 4 were related only to acute myocardial infarction, 5, 6 or were conducted specifically in an elderly population. 7, 8 To our knowledge, large-scale population-based studies with further age-and sex-specific analyses of incidence and relative risk of HF have rarely been reported. Coronary heart disease (CHD) is among the most frequent underlying causes of HF, 9 but apart from acute myocardial infarction, 5, 6 information on the risk estimates of HF related to other CHDs and coronary revascularization procedures is also very rare.
Haffner et al. 10 reported that people with type 2 diabetes who did not have a history of myocardial infarction had a risk of infarction similar to people without diabetes who did have a history of myocardial infarction. Since that report, diabetes has been regarded as "CHD-equivalent", 11 and aggressive management of cardiovascular risk factors are recommended in patients with diabetes. However, not all studies support the notion that diabetes is "CHD-equivalent", 12, 13 and one study concluded that "CHD risk equivalence" in diabetes depended on concomitant risk factors. 14 To our knowledge, the ascertainment of comparative risks for HF between people with type 2 diabetes and those without diabetes with or without CHD or coronary revascularization procedures has not been fully elucidated.
The aim of the present study was to use a nationally representative diabetes cohort selected from Taiwan's National Health Insurance (NHI) claims to investigate the incidence and relative risk of HF in people with and without type 2 diabetes, with particular reference to various age-and sex-stratified analyses. We also compared the risks of HF between people with type 2 diabetes and those without diabetes with and without various CHDs and coronary revascularization procedures. Our hypothesis was that if type 2 diabetes was "CHDequivalent", the relative risk of HF for type 2 diabetes without CHD would be similar to that for absence of type 2 diabetes with CHD.
| MATERIALS AND METHODS

| Data source
In 1995, Taiwan launched the NHI programme, 15 which has been implemented by the NHI Administration under the jurisdiction of the Ministry of Health and Welfare. By the end of 1995, the NHI programme covered some 96% of all Taiwan residents; the coverage rate increased to 99.7% by the end of 2016. 16 To ensure the accuracy of claim files, the NHI Administration performs quarterly expert reviews on a random sample for every 50 to 100 ambulatory and inpatient claims, 17 and information available from the NHI is considered to be complete and accurate. 18 With ethical approval from the Review Committee of National Health Research Institutes, we used claim data 
| Study design and subjects
This was a population-based cohort study of type 2 diabetes retrieved from ambulatory care claims with International 
| Statistical analysis
Estimates of age-and sex-specific incidence density were calculated with person-years as the denominator under the Poisson assumption. Table 1) .
The overall and age-and sex-specific incidence densities and hazard ratios (HRs) of HF are presented in Table 2 . The overall incidence density for men and women with type 2 diabetes was 19.2 and 22.0 per 1000 person-years, respectively, while the corresponding figures for men and women in the control group were much lower at 11.1 and 12.7 per 1000 person-years. In both groups, the incidence density of HF increased with age, and the highest incidence density was found in the age group >65 years, irrespective of diabetes status.
Generally, the age-and sex-specific incidence density of HF was higher in people with type 2 diabetes than in control subjects.
Men and women with type 2 diabetes were observed to experience an increased hazard of HF with a covariate-adjusted HR (aHR) of Because of a significant interaction of type 2 diabetes status with age (P < 0.0001) for both men and women, we performed age-stratified analyses to estimate the age-specific HR for both men and women with type 2 diabetes. Those with type 2 diabetes aged <45 years had the highest HRs: aHR 2.54 (95% CI 1.62-3.98) in men and aHR 4.12 (95% CI 2.35-7.23) in women ( Table 2) . Table 3 shows overall and sex-specific relative hazards of HF in association with various CHDs and revascularization procedures among people with type 2 diabetes and people without diabetes.
Compared with the control subjects without any heart disease, the risk of HF in type 2 diabetes without any heart disease was significantly higher, with an aHR of 1.56 (95% CI 1.46-1.66). This risk Sex-specific analyses showed that men in the control group tended to experience higher HRs than women in the control group for most CHDs and revascularization procedures except chronic ischaemic heart disease and percutaneous transluminal coronary angiography.
By contrast, women in the type 2 diabetes group tended to have higher HRs than their male counterparts, with the exceptions of acute myocardial infarction, angina pectoris and coronary artery bypass surgery (Table 3) . 
| DISCUSSION
Previous studies, 10, 21, 22 reported that patients with diabetes but without a history of myocardial infarction tended to have a risk of CHD death similar to that of individuals without diabetes who had experienced a previous myocardial infarction; therefore, diabetes has been regarded as "CHD-equivalent". 11 To the best of our knowledge, however, there has been only one study comparing the risk of HF between women with diabetes and women without diabetes with CHD. 23 In that study, the Raloxifene Use for the Heart (RUTH) trial, the authors found that the risk of congestive HF was also similar among women with diabetes without CHD and women without diabetes with CHD.
The present study also showed that the risk of HF in type 2 diabetes without a history of CHD was similar to that in control subjects with a history of CHD; this was observed for both men and women.
Unlike the present study, the study by Howard et al 14 indicated
that men and women with diabetes and without previous cardiovascular disease had lower overall 10-year cumulative CHD incidence rates than did men and women without diabetes and with previous CHD. A Danish study 24 indicated that, as compared to men without diabetes but with previous cardiovascular disease, the risk of cardiovascular events was significantly lower in men with diabetes but Table 1 , and selected medications (statin, β-blockers and diuretics). d Based on Cox proportional hazard regression with adjustment for age, geographical area, urbanization status, history of coronary heart diseases and coronary revascularization procedures listed in Table 1 , and selected medications (statin, β-blockers and diuretics). e Based on Cox proportional hazard regression with adjustment for age, sex, geographical area, urbanization status, history of coronary heart diseases and coronary revascularization procedures listed in Table 1 , and selected medications (statin, β-blockers and diuretics). findings. Some studies reported that established CHD signified a higher risk of CHD mortality than did diabetes in men, and this was reversed in women, with diabetes being associated with a greater risk of CHD mortality, 25, 26 but other studies reported that the risk of total and CHD death was not significantly different between people with diabetes only and people with myocardial infarction only among men, whereas it was even higher in the diabetes-only group among women. 27 Very few studies have reported the risk of HF in association with various CHDs other than acute myocardial infarction. 5, 6 In the present study, coronary artery bypass surgery was associated with the highest increased HR of HF, followed by acute myocardial infarction and percutaneous transluminal coronary angiography. 29 One previous study 4 showed that the relative risk of HF in relation to diabetes increased with decreasing age, which is also consistent with our findings. Both the Framingham study 30 and a study from England 29 reported higher hazards of congestive HF in women than in men with diabetes. Similarly, the HRs of HF for women with type 2 diabetes in the present study were much higher in those aged <45 years, but the differences in sex-specific HR became smaller with increasing age.
The estimated incidence of HF in the present control group was higher than that reported in a population-based study from West London, UK, 31 was similar to that of men in the Framingham Heart Study, 32 but was lower than findings from the HMO of Portland, Oregon, United States. 4 Such discrepancies were probably attributable to dissimilarity in baseline demographic characteristics, methods of outcome ascertainment and variation in period of follow-up.
The underlying pathogenesis for HF in association with diabetes has not been fully elucidated. Apart from the coexistence of myocardial ischaemia and hypertension, the excessive myocardial free fatty acid uptake and metabolism in diabetes cause lower left ventricular function, increase mitochondrial reactive oxygen stress, and exert lipotoxic effects in myocardial cells. 33, 34 In addition, excessive deposition of advanced glycation end products initiates inflammatory signalling and propagates apoptosis, fibrotic remodelling and immune cell infiltration, 35 and also constitutes a driving factor for cardiomyocyte stiffness and myocardial collagen deposition. 36 Accompanying autonomic dysfunction and subsequent activation of the neuro-hormonal compensatory systems led to the progressive loss of cardiac myocytes and a downward spiral of cardiac failure. 37 Moreover, recent studies reported associations of certain antidiabetes drugs with increased risk of HF. Available data suggest that thiazolidinediones may precipitate HF. 38 A recent Taiwanese study reported that, as compared with acarbose, glinides may be associated with a higher risk of HF for people with type 2 diabetese. 39 Such findings are generally consistent with the present data.
The present study had several methodological strengths. First, both the type 2 diabetes and control groups were retrieved from the NHI database, which is population-based and is highly representative, causing little possibility of selection bias. In addition, there is also little likelihood of non-response and loss to follow-up of cohort members.
Information on disease was obtained from medical claims rather than self-reports, which reduces the chance of recall bias. Second, one of the potential advantages of using insurance claim datasets in clinical research is easy access to the longitudinal records for a large sample of patients from different geographical areas. 40 Third, such a large number of study subjects also made it possible for us to make ageand sex-stratified analyses without compromising statistical power.
Fourth, because the diagnostic procedures of HF can be dependent on medical resources and physicians' behaviour, adjustment for geographical area and urbanization status made it possible to reduce such geographical and urbanization-related confounding.
In spite of the above strengths, the study also has several limitations. First, exclusive reliance on the claims data might have resulted in potential disease misclassification bias. The accuracy of a single diabetes diagnosis in the NHI claim data in 2000 was reported to be 74.6%, 41 but we used at least two diagnoses of type 2 diabetes, with the first and the last visits >30 days apart, which may reduce the likelihood of disease misclassification. Despite that, the control group might still have included people with new-onset or undiagnosed diabetes. Such misclassification bias, however, was likely to be non-differential, which tends to underestimate rather than overestimate the true relative risks. 42 Second, a number of potential confounders including body mass index, disease duration, physical activities, smoking and alcohol consumption were not considered in our analysis, mainly because of the unavailability of these data. Inadequate adjustment for potential confounders might have resulted in residual confounding. Third, our exclusive reliance on inpatient claims for the diagnosis of HF would have missed some of the patients who were not hospitalized, which could underestimate the incidence rate, but it would have had little influence on the relative risk estimates associated with type 2 diabetes. Lastly, data analysed in this study were entirely from ethnic Chinese people; the findings may not therefore be generalizable to other ethnic populations.
In conclusion, after a 12-year follow-up period, the men and women with type 2 diabetes in this population in Taiwan 
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